HEADER PROTEIN 08-MAR-17 5NDA TITLE NMR STRUCTURAL CHARACTERISATION OF PHARMACEUTICALLY RELEVANT PROTEINS TITLE 2 OBTAINED THROUGH A NOVEL RECOMBINANT PRODUCTION: THE CASE OF THE TITLE 3 PULMONARY SURFACTANT POLYPEPTIDE C ANALOGUE RSP-C33LEU. COMPND MOL_ID: 1; COMPND 2 MOLECULE: RSP-C33LEU -RECOMBINANT PULMONARY SURFACTANT-ASSOCIATED COMPND 3 POLYPEPTIDE C ANALOGUE-; COMPND 4 CHAIN: A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS PROTEIN, PULMONARY SURFACTANT PROTEIN, SP-C ANALOGUE, RECOMBINANT KEYWDS 2 PROTEIN, SOLUBILITY TAG, FUSION PROTEIN, NT DOMAIN, PROTEIN KEYWDS 3 STRUCTURE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR L.VENTURI,B.PIOSELLI,J.JOHANSSON,A.RISING,N.KRONQVIST,K.NORDLING REVDAT 4 14-JUN-23 5NDA 1 REMARK REVDAT 3 08-MAY-19 5NDA 1 REMARK REVDAT 2 13-SEP-17 5NDA 1 REMARK REVDAT 1 07-JUN-17 5NDA 0 JRNL AUTH N.KRONQVIST,M.SARR,A.LINDQVIST,K.NORDLING,M.OTIKOVS, JRNL AUTH 2 L.VENTURI,B.PIOSELLI,P.PURHONEN,M.LANDREH,H.BIVERSTAL, JRNL AUTH 3 Z.TOLEIKIS,L.SJOBERG,C.V.ROBINSON,N.PELIZZI,H.JORNVALL, JRNL AUTH 4 H.HEBERT,K.JAUDZEMS,T.CURSTEDT,A.RISING,J.JOHANSSON JRNL TITL EFFICIENT PROTEIN PRODUCTION INSPIRED BY HOW SPIDERS MAKE JRNL TITL 2 SILK. JRNL REF NAT COMMUN V. 8 15504 2017 JRNL REFN ESSN 2041-1723 JRNL PMID 28534479 JRNL DOI 10.1038/NCOMMS15504 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 3.97, OPAL 3.97 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 LUGINBUHL, GUNTERT, BILLETER AND WUTHRICH (OPAL) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NDA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1200003777. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 1 REMARK 210 IONIC STRENGTH : / REMARK 210 PRESSURE : AMBIENT ATM REMARK 210 SAMPLE CONTENTS : 1.7 MM NO RSP-C33LEU REMARK 210 -RECOMBINANT PULMONARY REMARK 210 SURFACTANT-ASSOCIATED REMARK 210 POLYPEPTIDE C ANALOGUE-, CDCL3/ REMARK 210 CD3OD/0.1 M HCL 32:64:5 (V/V) REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H COSY; 2D 1H-1H TOCSY; REMARK 210 2D 1H-1H NOESY; 2D 1H-15N HSQC; REMARK 210 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : A REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, CARA, TALOS REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 PRO A 2 45.99 -75.54 REMARK 500 5 SER A 3 13.35 49.50 REMARK 500 7 PRO A 2 104.78 -55.12 REMARK 500 7 SER A 3 -63.57 -167.79 REMARK 500 13 SER A 3 -56.70 -149.64 REMARK 500 14 SER A 3 -83.90 -131.23 REMARK 500 18 SER A 3 -147.98 -154.76 REMARK 500 18 SER A 4 154.37 -47.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34114 RELATED DB: BMRB REMARK 900 NMR STRUCTURAL CHARACTERISATION OF PHARMACEUTICALLY RELEVANT REMARK 900 PROTEINS OBTAINED THROUGH A NOVEL RECOMBINANT PRODUCTION: THE CASE REMARK 900 OF THE PULMONARY SURFACTANT POLYPEPTIDE C ANALOGUE RSP-C33LEU. DBREF 5NDA A 1 33 PDB 5NDA 5NDA 1 33 SEQRES 1 A 33 ILE PRO SER SER PRO VAL HIS LEU LYS ARG LEU LYS LEU SEQRES 2 A 33 LEU LEU LEU LEU LEU LEU LEU ILE LEU LEU LEU ILE LEU SEQRES 3 A 33 GLY ALA LEU LEU LEU GLY LEU HELIX 1 AA1 SER A 4 LEU A 29 1 26 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1